U.S. Markets open in 6 hrs 16 mins

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.8800+0.21 (+0.52%)
At close: 4:02PM EDT
People also watch
Interactive chart
Previous Close40.6700
Bid0.0000 x
Ask0.0000 x
Day's Range40.4900 - 41.3000
52 Week Range27.5300 - 43.6200
Avg. Volume310,253
Market Cap2.14B
PE Ratio (TTM)-80.16
EPS (TTM)-0.51
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est41.29
Trade prices are not sourced from all markets
  • GuruFocus.comyesterday

    Haemonetics Corp (HAE) Files 10-K for the Fiscal Year Ended on March 31, 2017

    Haemonetics Corp (NYSE:HAE) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017.

  • PR Newswire3 days ago

    Haemonetics Sets Date for Investor / Analyst Meeting - June 19, 2017

    BRAINTREE, Mass., May 22, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that it will host an investor and analyst meeting on Monday, June 19 th from 10:00am to 2:00pm Eastern Time ...

  • Capital Cube7 days ago

    Haemonetics Corp. – Value Analysis (NYSE:HAE) : May 19, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Haemonetics Corp. a score of 21. Our analysis is based on comparing Haemonetics Corp. with the following peers – Thermo Fisher Scientific Inc., Stryker Corporation, Becton, Dickinson and Company, C. R. Bard, Inc., Cerus Corporation, Baxter International Inc., PerkinElmer, Inc., Cytori Therapeutics, Inc., HemaCare Corporation and Johnson ... Read more (Read more...)